Welcome: Guest | Site Use Options | Register | Login |

Autonomous Therapeutics Inc

Autonomous Therapeutics Inc

Profile last edited on: 8/24/2021
101 6th Avenue
New York, NY 10013
  (301) 502-7772
Business Identifier: Varient-proof antivirals
Public Profile:
With facilities in New York, NY and in Rockville, MD and having strong ties to Harvard Medical and UCSF, Autonomous Therapeutics Inc is structured around development of broad-spectrum resistance-proof antivirals. An alumni of the NYC JLabs. and having a straight to Phase II DARPA SBIR Award, the firm's interdisciplinary team of virologists, synthetic biologists & robotics engineers are working on first-in-class pan-genus, broad-spectrum antivirals from COVID-19 to influenza. The driving theme is to ensure that effective countermeasures are ready before the next pandemic emerges.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
First-in-Human Therapeutic Interfering Particle (TIP) Targeting a Respiratory Virus

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920